| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.37 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |